Skip to main content
. 2019 May 28;9:377. doi: 10.3389/fonc.2019.00377

Table 4.

Local progression rates for 64 small lesions (< 2cm) according to the tumor size and SRS dose prescribed.

Local progression
Yes No Total
Size-dose TS < 1 cm Count 1 6 7
group 22–24 Gy/1 fx % within group 11.1% 66.7% 100.0%
TS < 1 cm Count 4 13 17
18–20 Gy/1 fx % within group 23.5% 76.5% 100.0%
TS < 1 cm Count 3 2 5
12–16 Gy/1 fx % within group 60.0% 40.0% 100.0%
TS 1.1–2 cm Count 0 3 3
22–24 Gy/1 fx % within group 0.0% 100.0% 100.0%
TS 1.1–2 cm Count 3 12 15
18–20 Gy/1 fx % within group 18.8% 75.0% 100.0%
TS 1.1–2 cm Count 9 8 17
12–16 Gy/1 fx % within group 52.9% 47.1% 100.0%
Total Count 20 44 64
% within group 29.9% 65.7% 100.0%

Lesions for which the response was not known were excluded.

TS, tumor size (diameter). Chi-square test not valid because of small numbers in some cells.